A novel submucosal injection solution for endoscopic resection of large colorectal lesions: A randomized, double-blind trial
Gastrointestinal Endoscopy May 25, 2018
Repici A, et al. - Given that SIC-8000 (Eleview) is a new FDA-approved solution for submucosal injection developed to provide a long-lasting cushion to facilitate endoscopic resection maneuvers, the researchers compared the efficacy and safety of SIC-8000 with those of saline solution, when performing endoscopic mucosal resection (EMR) of large colorectal lesions. The results obtained from this randomized double-blind trial indicate that a new FDA approved agent for sub-mucosal injection seemed to be a more powerful and equally safe submucosal agent for EMR injection than saline solution.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries